Short-term stability of a new generic sodium ferric gluconate in complex with sucrose

Current Medical Research and Opinion

Volumn 27, Issue 12, 2011, Pages 2241-2243

  Baribeault, David ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Ferric gluconate; Pharmaceutical technology; Stability

Indexed keywords

FERRIC GLUCONATE; IRON; SUCROSE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DRUG APPROVAL; DRUG STABILITY; DRUG STORAGE; FOOD AND DRUG ADMINISTRATION; FREEZING; MOLECULAR WEIGHT; PRESCRIPTION; ROOM TEMPERATURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CHILD; DRUG STABILITY; DRUGS, GENERIC; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HUMANS; MALE; MIDDLE AGED; SUCROSE; SWEETENING AGENTS;

EID: 81855184894     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.628304     Document Type: Article

References (3)

1. Ferrlecit [prescribing information]. Bridgewater, NJ, USA: sanofi-aventis U.S. LLC, 2010
2. Nulecit [prescribing information]. Corona, CA, USA: Watson Pharma Inc., 2010
3. Baribeault D. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers. Curr Med Res Opin 2011;27:1653-57